This week, a 43-year-old white male presents at the office with a chief complaint of pain. He is assisted in his ambulation with a set of crutches. At the beginning of the clinical interview, the client reports that his family doctor sent him for psychiatric assessment because the doctor felt that the pain was “all in his head.” He further reports that his physician believes he is just making stuff up to get “narcotics to get high.”
Write a 1- to 2-page summary paper that addresses the following:
Briefly summarize the patient case study you were assigned, including each of the three decisions you took for the patient presented.
Based on the decisions you recommended for the patient case study, explain whether you believe the decisions provided were supported by the evidence-based literature. Be specific and provide examples. Be sure to support your response with evidence and references from outside resources.
What were you hoping to achieve with the decisions you recommended for the patient case study you were assigned? Support your response with evidence and references from outside resources.
Explain any difference between what you expected to achieve with each of the decisions and the results of the decision in the exercise. Describe whether they were different. Be specific and provide examples.
Solution Preview
Assessing and Treating Clients with Hip Pain
Introduction
The patient is aged 43 and is of white origin. The patient has been presented to the health setting with the complaint of hip pain. He is using crutches and during the initial process of assessment of the patient, he indicates that the family doctor sent him to a psychiatrist because of the assertion that the pain was in his head. He points out that the family doctor has the assertion that he is making stuff up. He alludes that the issue of pain in his hip began 7 years ago when he had a fall. This paper helps in the assessment of the medication for this patient.
Decision Point One
The first option that is taken into consideration is to use Savella 12.5 mg orally once daily on day 1; followed by 12.5 mg BID on day 2 and 3; followed by 25 mg BID on days 4-7; followed by 50 mg BID thereafter. The reason for the selection of this decision is that it will help in working on the nerve endings with the production of analgesic effects as alluded to by Stanton-Hicks (2018). The use of the medication will help in the enhancement of the reuptake of the neurotransmitters in the brain. This helps in the reduction of pain….
(click here to get full solution)